Bacterial resistance to silver nanoparticles and how to overcome it
By A. Panáček, L. Kvítek, M. Smekalova, R. Večeřová, M. Kolář, M. Röderová, F. Dyčka, M. Šebela, R. Prucek, Ondřej Tomanec and 1 more. Nature Nanotechnology, 2017
830 citations recorded by the source corpus.
Subfields: Materials Chemistry, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/e8b0c1e73075599cc34124b2711f7a3e7697ad1a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies (2018, background): “This resistance was due to the production of flagellin, an adhesive protein of the bacterial flagellum, which caused the aggregation of AgNPs and thereby eliminated their antibacterial effect.(52) Indeed, bacterial resistance exists, and the mechanism is the aggregation of AgNPs.”
- Antibacterial approaches in tissue engineering using metal ions and nanoparticles: From mechanisms to applications (2021, background): “[56] described the agglomeration of 20 nm Ag-NPs due to”
- Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans” (2018, background): “Although, this is usually believed to be the case, there are some studies reporting development of bacterial resistance against silver NPs (Panáček et al., 2018).”
- Face Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives (2020, background): “The wide usage of some metal NPs, especially silver, has led to some bacterial resistance against these agents [242, 243].”
- Silver nanoparticles: Synthesis, medical applications and biosafety (2020, background): “Unlike the risk of antibiotic resistance which may limit medical applications, rare AgNPs resistance of bacteria is observed [20].”